ACET MEDICA AB require funding for finalizing research and investigations, finalizing laboratory tests, further production tests and development, until the product is approved and ready for introduction into global markets.
ACET MEDICA AB is engaged in multiple negotiations with potential, strategic pharmaceutical companies to manufacture and distribute the productline in 70 countries.
ACET MEDICA AB is available for negotiations with potentially interested partners and onboarding investors who aim for company shares.
«To create a quick pain relief is difficult, but our product is just that!»
– Roar Adelsten, CEO
HERPES SIMPLEX GENITALIS ZOSTER
INSECTS MOSQUITOS STINGS
SUNBURN JELLYFISH NETTLES
© Copyright ACET MEDICA AB 2019